Golixen 150 Tablet

About Golixen 150 Tablet

Golixen 150 is a 150 mg tablet containing elagolix, used for moderate to severe pain linked to endometriosis. It is a gonadotropin-releasing hormone antagonist that works by reducing the growth of endometrial-like tissue.

There are 8 brands of Elagolix listed in Bangladesh. The lowest listed price is Elagox 150 mg Tablet at ৳ 170.00 per unit.

What is Golixen 150 Tablet?

Golixen 150 is a tablet form of elagolix, a gonadotropin-releasing hormone (GnRH) antagonist. It is prescribed for the management of moderate to severe pain associated with endometriosis, a condition where tissue similar to the uterine lining grows outside the uterus. These growths depend on estrogen, and elagolix reduces the hormones that drive their growth, which helps lessen pain. The 150 mg strength is one available option. The dose and treatment duration are decided by the doctor based on the individual case. This medicine is not for use during pregnancy.

Uses of Golixen 150

Golixen 150 is used to manage moderate to severe pain caused by endometriosis. Endometriosis can cause pain during periods, pelvic pain between periods, and pain during sexual intercourse. Elagolix works by blocking a hormone receptor that helps control estrogen, which in turn may reduce the growth and activity of endometrial-like tissue outside the uterus. The doctor decides how long treatment should continue.

How to use Golixen 150

Golixen 150 is taken as a tablet by mouth, usually at about the same time each day, with or without food. Before starting, pregnancy must be ruled out or treatment started within the first week of a menstrual period. The doctor sets the dose and course based on the condition and response. Do not change the dose or stop the medicine without medical advice.

Side effects of Golixen 150

Common side effects reported with elagolix include hot flushes, night sweats, headache, nausea, insomnia, missed periods, anxiety, joint pain, and mood changes or depression-related symptoms. Some people may experience other effects. Contact a doctor if side effects are bothersome or persistent, especially mood changes, depression, or thoughts of self-harm. The doctor can advise on managing side effects.

Safety and precautions

Golixen 150 is contraindicated during pregnancy and may increase the risk of early pregnancy loss, so pregnancy must be excluded before starting and effective non-hormonal contraception used during treatment. It is also contraindicated in women with known osteoporosis or severe liver impairment. It may reduce bone mineral density in a dose- and duration-dependent way. Tell the doctor about any liver problems, bone disease, depression, or use of other medicines. The doctor should assess individual risks before prescribing.

Frequently asked questions

What does the dosage form and strength mean for Golixen 150?

Golixen 150 comes as a tablet, a solid form taken by mouth. The strength is 150 mg, meaning each tablet contains 150 milligrams of the active ingredient elagolix. The doctor decides the dose and how often it should be taken.

What is Golixen 150 used for and what kind of medicine is it?

Golixen 150 is used for moderate to severe pain associated with endometriosis. It is a gonadotropin-releasing hormone (GnRH) antagonist, a type of medicine that blocks a hormone receptor involved in controlling estrogen. The doctor decides the dose and duration of treatment.

What does the generic name elagolix mean?

Elagolix is the generic name of the active substance in Golixen 150. The brand name is Golixen 150. Knowing the generic name helps identify the medicine and compare it with other products that contain the same ingredient.

Can Golixen 150 be used during pregnancy?

No, Golixen 150 is contraindicated in pregnancy because exposure early in pregnancy may increase the risk of early pregnancy loss. Pregnancy should be excluded before starting treatment, and effective contraception is needed during treatment. If pregnancy occurs, stop the medicine and contact a doctor immediately.

Indications

Elagolix is indicated for the management of moderate to severe pain associated with endometriosis.

Pharmacology

Endometriosis develops when tissue that is similar to the kind that is normally located in the uterus starts to grow outside of the uterus. Such growth leads to various symptoms like pain during periods, pelvic pain between periods, and pain during sexual intercourse. The growths themselves are referred to as lesions and frequently develop on the ovaries, fallopian tubes, and other areas around the uterus, including the bowel or bladder. The growth of these lesions is dependent upon the estrogen hormone.

Elagolix is an orally-administered, nonpeptide small molecule gonadotropin-releasing hormone (GnRH) receptor antagonist that inhibits endogenous GnRH signaling by binding competitively to GnRH receptors in the pituitary gland Label. Administration of elagolix results in dose-dependent suppression of luteinizing hormone (LH) and follicle-stimulating hormone (FSH), leading to decreased blood concentrations of the ovarian sex hormones, estradiol and progesterone.

Dosage & Administration

Exclude pregnancy before starting Elagolix or start Elagolix within 7 days from the onset of menses. Take Elagolix at approximately the same time each day, with or without food.

Initiate treatment with Elagolix 150 mg once daily-
  • Maximum Treatment Duration: 24 months
  • Coexisting Condition: None
Consider initiating treatment with Elagolix 200 mg twice daily-
  • Maximum Treatment Duration: 6 months
  • Coexisting Condition: Dyspareunia
Initiate treatment with Elagolix 150 mg once daily. Use of 200 mg twice daily is not recommended-
  • Maximum Treatment Duration: 6 months
  • Coexisting Condition: Moderate hepatic impairment (Child-Pugh Class B)

Interaction

May potentiate P-gp substrates (eg. Digoxin), CYP2C19 substrates (eg. Dose limit of Omeprazole is upto 40mg daily). May antagonize CYP3A substrates. Antagonizes oral Midazolam, Rosuvastatin; consider increasing their doses. Maybe antagonized by CYP3A inducers. Reduces efcacy with estrogen-containing contraceptives.

Contraindications

Elagolix is contraindicated in women:
  • Who are pregnant
  • Exposure to ORILISSA early in pregnancy may increase the risk of early pregnancy loss.
  • With known osteoporosis because of the risk of further bone loss
  • With severe hepatic impairment because of the risk of bone loss
  • With concomitant use of strong organic anion transporting polypeptide (OATP) 1B1 inhibitors (e.g., cyclosporine and gemfibrozil)

Side Effects

Most common adverse reactions (>5%) in clinical trials included hot flushes and night sweats, headache, nausea, insomnia, amenorrhea, anxiety, arthralgia, depression-related adverse reactions and mood changes.

Pregnancy & Lactation

Exposure to Elagolix early in pregnancy may increase the risk of early pregnancy loss. Use of Elagolix is contraindicated in pregnant women. Discontinue Elagolix if pregnancy occurs during treatment. The limited human data with the use of Elagolix in pregnant women are insufficient to determine whether there is a risk for major birth defects or miscarriage. Although two cases of congenital malformations were reported in clinical trials with Elagolix, no pattern was identified and miscarriages were reported at a similar incidence across treatment groups. There is no information on the presence of elagolix or its metabolites in human milk, the effects on the breastfed child, or the effects on milk production.

There are no adequate animal data on the excretion of Elagolix in milk. The developmental and health benefits of breastfeeding should be considered along with the mother’s clinical need for Elagolix and any potential adverse effects on the breastfed child from Elagolix.

Precautions & Warnings

  • Bone Loss: Dose- and duration-dependent decreases in bone mineral density (BMD) that may not be completely reversible. Assess BMD in women with additional risk factors for bone loss
  • Reduced Ability to Recognize Pregnancy: Elagolix may alter menstrual bleeding, which may reduce the ability to recognize pregnancy. Perform testing if pregnancy is suspected. Discontinue if pregnancy is confirmed
  • Suicidal Ideation and Mood Disorders: Advise patients to seek medical attention for suicidal ideation, suicidal behavior, new onset or worsening depression, anxiety, or other mood changes
  • Hepatic Transaminase Elevations: Dose-dependent elevations in serum alanine aminotransferase (ALT). Counsel patients on signs and symptoms of liver injury
  • Potential for Reduced Efficacy with Estrogen-Containing Contraceptives: Use non-hormonal contraception during treatment and for one week after discontinuing Elagolix.

Overdose Effects

In case of overdose, patients should be monitored for any signs or symptoms of adverse reactions and initiate appropriate symptomatic treatment, as needed.

Storage Conditions

Keep below 30°C temperature, away from light & moisture. Keep out of the reach of children.

Alternative brands of Elagolix

Other brands with the same generic name, cheapest first.

Elagox Tablet

150 mg

Elagolix

Nuvista Pharma Ltd

৳ 170.00 per unit

Medicine information is for reference only and is not medical advice. Always follow your doctor's prescription and check with a pharmacist.